Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review

BACKGROUND: Transcatheter arterial chemoembolization has been widely used in patients with hepatocellular carcinoma. However, double blood supply and the existence of portal vein tumor thrombus influence the efficacy of transcatheter arterial chemoembolization. MAIN BODY: Theoretically, portal vein...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Zhiying, Liu, Xin, Peng, Chanjuan, Wang, Liping, Xu, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487116/
https://www.ncbi.nlm.nih.gov/pubmed/34598689
http://dx.doi.org/10.1186/s12957-021-02401-4
_version_ 1784577888336478208
author Shao, Zhiying
Liu, Xin
Peng, Chanjuan
Wang, Liping
Xu, Dong
author_facet Shao, Zhiying
Liu, Xin
Peng, Chanjuan
Wang, Liping
Xu, Dong
author_sort Shao, Zhiying
collection PubMed
description BACKGROUND: Transcatheter arterial chemoembolization has been widely used in patients with hepatocellular carcinoma. However, double blood supply and the existence of portal vein tumor thrombus influence the efficacy of transcatheter arterial chemoembolization. MAIN BODY: Theoretically, portal vein embolization combined with transcatheter arterial chemoembolization may bring a breakthrough in the therapeutic effect of hepatocellular carcinoma. The feasibility, efficacy, long-term survival benefits, and side effects of the combined treatment have been explored in previous studies. Chemotherapeutic agents may also be added in the portal vein embolization procedure to further improve the treatment response. CONCLUSION: In this study, we review the existing data and studies on the combined treatment in patients with hepatocellular carcinoma and provide an overall view of the strategy.
format Online
Article
Text
id pubmed-8487116
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84871162021-10-04 Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review Shao, Zhiying Liu, Xin Peng, Chanjuan Wang, Liping Xu, Dong World J Surg Oncol Review BACKGROUND: Transcatheter arterial chemoembolization has been widely used in patients with hepatocellular carcinoma. However, double blood supply and the existence of portal vein tumor thrombus influence the efficacy of transcatheter arterial chemoembolization. MAIN BODY: Theoretically, portal vein embolization combined with transcatheter arterial chemoembolization may bring a breakthrough in the therapeutic effect of hepatocellular carcinoma. The feasibility, efficacy, long-term survival benefits, and side effects of the combined treatment have been explored in previous studies. Chemotherapeutic agents may also be added in the portal vein embolization procedure to further improve the treatment response. CONCLUSION: In this study, we review the existing data and studies on the combined treatment in patients with hepatocellular carcinoma and provide an overall view of the strategy. BioMed Central 2021-10-01 /pmc/articles/PMC8487116/ /pubmed/34598689 http://dx.doi.org/10.1186/s12957-021-02401-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Shao, Zhiying
Liu, Xin
Peng, Chanjuan
Wang, Liping
Xu, Dong
Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review
title Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review
title_full Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review
title_fullStr Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review
title_full_unstemmed Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review
title_short Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review
title_sort combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487116/
https://www.ncbi.nlm.nih.gov/pubmed/34598689
http://dx.doi.org/10.1186/s12957-021-02401-4
work_keys_str_mv AT shaozhiying combinationoftranscatheterarterialchemoembolizationandportalveinembolizationforpatientswithhepatocellularcarcinomaareview
AT liuxin combinationoftranscatheterarterialchemoembolizationandportalveinembolizationforpatientswithhepatocellularcarcinomaareview
AT pengchanjuan combinationoftranscatheterarterialchemoembolizationandportalveinembolizationforpatientswithhepatocellularcarcinomaareview
AT wangliping combinationoftranscatheterarterialchemoembolizationandportalveinembolizationforpatientswithhepatocellularcarcinomaareview
AT xudong combinationoftranscatheterarterialchemoembolizationandportalveinembolizationforpatientswithhepatocellularcarcinomaareview

Ejemplares similares